| 2.21 Delayed Data As of Aug 16 |  +0.09 / +4.25%Today’s Change | 1.81 Today|||52-Week Range 7.94 | -20.36% Year-to-Date |
| Previous close | 2.12 |
| Today’s open | 2.12 |
| Day’s range | 2.03 - 2.25 |
| Volume | 282,018 |
| Average volume (3 months) | 198,369 |
| Market cap | $42.0M |
| Dividend yield | -- |
| Earnings growth (last year) | +70.83% |
| Earnings growth (this year) | +24.76% |
| Earnings growth (next 5 years) | +1.00% |
| Revenue growth (last year) | -2.32% |
| P/E ratio | NM |
| Price/Sales | 5.38 |
| Price/Book | 2.18 |
| Today’s change | Today’s % change | |
|---|---|---|
| NVCNNeovasc Inc | 0.00 | 0.00% |
| AEMDAethlon Medical Inc | -0.12 | -1.82% |
| DXRDaxor Corp | -0.01 | -0.12% |
| ALQAAlliqua BioMedical I... | -0.02 | -1.77% |
| Next reporting date | November 3, 2016 |
| EPS forecast (this quarter) | -$0.40 |
| Annual revenue (last year) | $4.8M |
| Annual profit (last year) | -$19.4M |
| Net profit margin | -401.10% |
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Marc H. Hedrick |
CFO, Vice President & Head-Investor Relations Tiago Girão |
Corporate headquarters San Diego, California |
